India: Supreme Court asks Novartis to reduce cancer drug price
The Supreme Court of India recently, for the second time asked Novartis, the global pharmaceutical giant to reduce the price of its cancer drug Glivec. The cost per month for treatment with this drug would come up to INR 120,000, which is too high for even the middle income people to afford, let alone the poor. Read more here.
Featured Blog Posts
Get The Latest From The Social Sector In Your Inbox!
Subscribe to our newsletter
